AzTrials
AzTrials

BruxismNCT06289608

Bruxism and Underlying Psichological Factors

An observational study of Bruxism and Muscular Disorders, Atrophic, run by University of Salamanca at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study was o determine the relationship between self-reported bruxism (SB) and some psychological factors (i.e: Anxiety State-Trait; Stress Reactivity Index, Beck Depression Inventory). Read more about this study

Who is it for?
Ages 18 to 100 yearsHealthy volunteers can take part
How many people
100 participants
Where
1 siteSpain
Study dates
1 Feb 2023to 1 Mar 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Self-reported bruxists

Who may be able to join

  • Self-reported Bruxism

Who cannot join

  • Refused patients

Trial locations and contacts

1 site in 1 country.

JAVIER MONTERO, PRF contact

+34 619429971

javimont@usal.es

Departamento Cirugía contact

+34 923294400 ext. 1895

cirugia@usal.es

Spain1 site, 1 recruiting
  • Clinica Odontológica de la Universidad de Salamanca

    Salamanca, 37007

    JAVIER MONTERO, DDS, 619429971, javimont@usal.es

    Recruiting

Other trials in Spain

About this study

The aim of this study was o determine the relationship between self-reported bruxism (SB) and some psychological factors (i.e: Anxiety State-Trait; Stress Reactivity Index, Beck Depression Inventory). A consecutive sample of 101 patients that reported at least 2 of the 6 items of Bruxism self-reported index, were explored clinically for quantifying the number and severity of worn teeth, and also the severe and location of the muscular pain according to an standardized inventory.

Read the detailed description

The Bruxism Self-Reported Index was that reported by Pintado et al.

Pintado MR, Anderson GC, DeLong R, Douglas WH. Variation in tooth wear in young adults over a two-year period. J Prosthet Dent. 1997;77:313-320.

The muscular pain was assessed by the last version of the Research Diagnostic Criteria reported by the Schiffman et al in 2014

Schiffman E, et al ; International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache. 2014 Winter;28(1):6-27.

Being tested
No intervention
Medical subject headings
Bruxism, Muscular Disorders, Atrophic, Temporomandibular Joint Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

    No dental intervention was made. Only a clinical examination

Study groups in NCT06289608
Study groupRoleWhat they receive
Self-reported BruxismThose dental patients responding positively to at least 2 of the 6 items of the Pintado et al Self-reported Bruxism Inventory
Receives: Other: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression Level

    Beck Depression Index. The score range between 0-63, being proprotional to the current depression level

    Measured: baseline

  2. Stress Level

    Stress Reactitivy Index: Each of the 32 items are coded in a 4-point likert scale format, being 4 the worst category. The summary score is a proportional estimation of the stress level and range from 0-0.5 (minor stress), 0.6-1 (moderate stress) and >1 (severe stress)

    Measured: baseline

  3. Anxiety

    State-Trait Inventory has two estimation of anxiety, as a trait (assessed by 26 items) and as a transitory state (assessed by 20 items). All the items are coded in a 0-3 likert scale. The total score is proportional to the anxiety, being the threshold for determining anxiety above 20 points in male and 25 in females.

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2024
  2. Study start1 Feb 2023
  3. Primary completion1 Mar 2024 (estimated)
  4. Study completion1 Mar 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06289608
Sponsor's protocol ID
ID_2024
Status last verified
Feb 2023
First submitted
21 Feb 2024
Last updated
4 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The aggregated data will be published in a paper of the JCR Dentistry group

Questions about this trial

What is this clinical trial studying?

An observational study of Bruxism and Muscular Disorders, Atrophic, run by University of Salamanca at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact JAVIER MONTERO, PRF (+34 619429971, javimont@usal.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression Level (time frame: baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in